Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
JE Chaft, A Rimner, W Weder, CG Azzoli… - Nature reviews Clinical …, 2021 - nature.com
The treatment goal for patients with early-stage lung cancer is cure. Multidisciplinary
discussions of surgical resectability and medical operability determine the modality of …
discussions of surgical resectability and medical operability determine the modality of …
Contemporary radiotherapy: present and future
Oncology care is increasingly a multidisciplinary endeavour, and radiation therapy
continues to have a key role across the disease spectrum in nearly every cancer. However …
continues to have a key role across the disease spectrum in nearly every cancer. However …
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
JY Chang, RJ Mehran, L Feng, V Verma, Z Liao… - The Lancet …, 2021 - thelancet.com
Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an …
JY Chang, SH Lin, W Dong, Z Liao, SJ Gandhi, CM Gay… - The Lancet, 2023 - thelancet.com
Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or …
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or …
Integrated MRI-guided radiotherapy—opportunities and challenges
MRI can help to categorize tissues as malignant or non-malignant both anatomically and
functionally, with a high level of spatial and temporal resolution. This non-invasive imaging …
functionally, with a high level of spatial and temporal resolution. This non-invasive imaging …
Radiotherapy treatment for lung cancer: Current status and future directions
SK Vinod, E Hau - Respirology, 2020 - Wiley Online Library
Radiotherapy is an important modality used for the treatment of lung cancer. Seventy‐seven
percent of all patients with lung cancer have an evidence‐based indication for radiotherapy …
percent of all patients with lung cancer have an evidence‐based indication for radiotherapy …
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
Tumor genoty** is not routinely performed in localized non–small cell lung cancer
(NSCLC) due to lack of associations of mutations with outcome. Here, we analyze 232 …
(NSCLC) due to lack of associations of mutations with outcome. Here, we analyze 232 …
Radiotherapy and theranostics: A lancet oncology commission
Following on from the 2015 Lancet Oncology Commission on expanding global access to
radiotherapy, Radiotherapy and theranostics: a Lancet Oncology Commission was created …
radiotherapy, Radiotherapy and theranostics: a Lancet Oncology Commission was created …
The evolving role of radiotherapy in non-small cell lung cancer
Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality
worldwide with non-small cell lung cancer (NSCLC) accounting for most cases …
worldwide with non-small cell lung cancer (NSCLC) accounting for most cases …
Rational combinations of immunotherapy with radiotherapy in ovarian cancer
Except for its use in palliative care, radiotherapy has been largely abandoned in the
management of ovarian cancer because of the recognised efficacy and lower toxicity of …
management of ovarian cancer because of the recognised efficacy and lower toxicity of …